Bombay Hospital a.k.a. BHMRC is a private hospital in Mumbai, India. It was founded in 1950 by R. D. Birla. It has 830 beds, 110 of which are in the critical care and recovery area. It has 22 operating theatres, 3,200 full-time employees, 240 eminent consultants and 200 resident doctors.

During the past decade, Bombay Hospital Institute of Medical Sciences conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Bombay Hospital Institute of Medical Sciences" are "Acute Respiratory Failure" (1 trials), "Central Nervous System Diseases" (1 trials), "Diagnostic Imaging" (1 trials) and "General Safety Profile of DOTAREM" (1 trials). Many other conditions were trialed in "Bombay Hospital Institute of Medical Sciences" in a lesser frequency.

Most popular intervention types in "Bombay Hospital Institute of Medical Sciences" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Gadobutrol (Gadavist, Gadovist, BAY86-4875)" (1 trials) and "Gadoteridol (ProHance)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bombay Hospital Institute of Medical Sciences" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Bombay Hospital Institute of Medical Sciences". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Bombay Hospital Institute of Medical Sciences, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bombay Hospital Institute of Medical Sciences, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".